Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will assess the effectiveness of Nexium at alleviating upper GI symptoms in subjects and evaluate with which treatment regimen and on which indications acid suppression with isomeric proton pump inhibitor is used in routine clinical practice in Albania.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Frequency and severity of upper GI symptoms and the overall patient's discomfort during the last week. | Day 0 | |
| Frequency and severity of upper GI symptoms and the overall patient's discomfort during the last week. | Week 2-4 | |
| Frequency and severity of upper GI symptoms and the overall patient's discomfort during the last week. | Weeks 8-12 |
| Measure | Description | Time Frame |
|---|---|---|
| To follow the frequency, type and severity of symptoms in subjects consulting the doctors with upper GI symptoms. | Day 0 | |
| Evaluate with which treatment regimen and on which indications acid suppression with isomeric proton pump inhibitor is used in routine clinical practice in Albania. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Male or female subjects, age > 18 years, having had upper GI symptoms requiring acid suppression treatment.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Karin Otter, MD, PhD | Medical Director BBC | Study Director |
| Senka Riza | Medical and Regulatory Manager | Study Chair |
| Skerdi Prifti, Asc.Proff. | University Hospital Center "Mother Teresa" | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Berat | Albania | ||||
| Research Site |
Not provided
| ID | Term |
|---|---|
| D005764 | Gastroesophageal Reflux |
| D004381 | Duodenal Ulcer |
| ID | Term |
|---|---|
| D015154 | Esophageal Motility Disorders |
| D003680 | Deglutition Disorders |
| D004935 | Esophageal Diseases |
| D005767 | Gastrointestinal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Once: Day 0 |
| Evaluate the tolerability of Nexium in patients with upper GI symptoms by the number of participants with adverse events. | Day 0 |
| To follow the frequency, type and severity of symptoms in subjects consulting the doctors with upper GI symptoms. | Weeks 2-4 |
| To follow the frequency, type and severity of symptoms in subjects consulting the doctors with upper GI symptoms. | Weeks 8-12 |
| Evaluate the tolerability of Nexium in patients with upper GI symptoms by the number of participants with adverse events. | Weeks 2-4 |
| Evaluate the tolerability of Nexium in patients with upper GI symptoms by the number of participants with adverse events. | Weeks 8-12 |
| Burrel |
| Albania |
| Research Site | Durrës | Albania |
| Research Site | Elbasan | Albania |
| Research Site | Fier | Albania |
| Research Site | Kavajë | Albania |
| Research Site | Korçë | Albania |
| Research Site | Krujë | Albania |
| Research Site | Lezhë | Albania |
| Research Site | Lushnje | Albania |
| Research Site | Peshkopi | Albania |
| Research Site | Shkoder | Albania |
| Research Site | Tirana | Albania |
| Research Site | Vlorë | Albania |
| D004066 | Digestive System Diseases |
| D010437 | Peptic Ulcer |
| D004378 | Duodenal Diseases |
| D007410 | Intestinal Diseases |
| D013272 | Stomach Diseases |